Prs106 - The Assessment the Quality of Life in Children With Severe Persistent Uncontrolled Asthma, Receiving Omalizumab, by the Health Utilities Index and Standardised Paediatric Asthma Quality of Life Questionnaire(according to the Pediatric Registry)
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2919
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV